s.girard
TL2 · Angers
Contributes reviews on supplier material. Based in Angers.
Joined 27 June 2025 · last posted 2d
95 posts, newest first. Showing up to 150.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #57 · Clinical › Prescriber conversations · 26 Jul 2026 · 0 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
-
Pooling trials with different estimands Replied, post #127 · Evidence › Meta-analyses · 25 Jul 2026 · 7 likes What would change my mind on pooling trials with different estimands is a second dataset collected by someone with no stake in the first. Until then I hold it loosely…
-
A site rotation scheme that is easy enough to actually follow Replied, post #120 · Practice › Administration · 20 Jul 2026 · 15 likes Good question, well framed, and I would like to see it answered properly.
-
The headache that turns out to be dehydration — the long version Replied, post #70 · Nutrition & Training › Hydration & electrolytes · 20 Jul 2026 · 0 likes I read post #66 twice before replying, because I had assumed the opposite. Cramping is the symptom most confidently attributed to electrolytes and has the weakest…
-
Programming during a large energy deficit Replied, post #44 · Nutrition & Training › Resistance training · 19 Jul 2026 · 1 like Post #41 answers the question as asked. The question underneath it is different. Deload weeks matter more during a deficit than at maintenance because recovery is the…
-
Follow-up: UK access routes, dated and sourced Replied, post #13 · Regional › UK & Ireland · 19 Jul 2026 · 0 likes Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand…
-
Seven-day rolling means and why weekly readings mislead Replied, post #51 · Outcomes › Progress reports · 18 Jul 2026 · 15 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Why side effects reset at each escalation and that is not a failure Replied, post #5 · Practice › Side effects · 12 Jul 2026 · 1 like Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #98 · Evidence › Journal club · 11 Jul 2026 · 1 like Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
-
Why the timeline is on the right and not the left — what changed since Replied, post #71 · Meta › Site feedback · 10 Jul 2026 · 0 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment. Written in the hope of…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #27 · Analytics › Impurities & related substances · 26 Jun 2026 · 22 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #17 · Evidence › Meta-analyses · 19 Jun 2026 · 3 likes What I can speak to on Risk-of-bias tools is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
What to include when your question involves a chromatogram — one year on Replied, post #23 · Start Here › How to Ask · 2 Jun 2026 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #47 · Wellbeing › Sleep · 31 May 2026 · 5 likes Eating patterns shift substantially and late intake affects sleep independently of anything pharmacological. Written quickly, so the reasoning may be tighter than the…
-
Reporting a good result: why nobody bothers and why they should Replied, post #2 · Sourcing › Vendor reports · 7 May 2026 · 3 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. Selective submission and selective reporting are the two easiest ways for a…
-
Currency conversion and the cost you did not see Replied, post #2 · Sourcing › Payments · 30 Apr 2026 · 0 likes Escrow services: some third-party services hold payment until the buyer confirms receipt. They add cost but reduce risk if the supplier is unknown. This is where my…
-
The most useful thing you learned here that was not the answer you came for Replied, post #36 · Lounge › Off topic · 20 Apr 2026 · 10 likes Lounge question, no agenda: does anyone else keep a physical notebook for this rather than a file? Mine is more use than anything I have typed, and I cannot entirely…
-
Preservatives: function, testing, and limits — one year on Replied, post #11 · Pharmacology › Formulation chemistry · 19 Apr 2026 · 0 likes I read post #7 twice before replying, because I had assumed the opposite. The honest summary: a licensed formulation is a designed system and a reconstituted research…
-
Shoulders, tangent skims, and defensible integration — the long version Replied, post #21 · Analytics › HPLC & UHPLC · 17 Apr 2026 · 0 likes Everything in post #17 holds. The case it does not cover is the one I have. Trying to state the Shoulders position in a way that someone who disagrees would recognise…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #7 · Compounds › Oral incretins · 6 Apr 2026 · 22 likes PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled a diabetes population at high cardiovascular risk. Quoting it outside that population…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #87 · Practice › Reconstitution · 4 Apr 2026 · 0 likes Filing a mild objection to the consensus on Foaming during reconstitution. Mild because I might be wrong; an objection because nobody has addressed the case that does…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #77 · Pharmacology › Pharmacokinetics · 20 Mar 2026 · 0 likes Good question, well framed, and I would like to see it answered properly.
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #58 · Lounge › Introductions · 13 Mar 2026 · 0 likes Privacy: share only what you are comfortable making permanent and public. An introduction is archived and searchable; do not include information you will later regret…
-
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #10 · Practice › Dosing & titration · 6 Mar 2026 · 18 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Coming back to: How much context is too much context in a first post? Started this topic · Start Here › How to Ask · 5 Mar 2026 · 28 likes Asking directly, because I could not find a straight answer: How much context is too much context in a first post? Counting it rather than describing it, because the…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #32 · Practice › Administration · 1 Mar 2026 · 0 likes Alcohol swabbing and letting the site dry is the whole of the preparation for a subcutaneous injection into intact skin. Injecting before it dries is what stings. I…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #114 · Practice › Dosing & titration · 21 Feb 2026 · 22 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Revisiting: Absolute versus relative contraindications Replied, post #16 · Safety › Contraindications · 21 Feb 2026 · 0 likes My position on Absolute versus relative contraindications is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Anaesthesia and elective surgery: the aspiration question Replied, post #26 · Practice › Interactions · 19 Feb 2026 · 1 like Trying to state the anaesthesia and elective surgery position in a way that someone who disagrees would recognise as fair, because I do not think the version in this…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #39 · Evidence › Study critique · 9 Feb 2026 · 1 like Criticism is more useful when it is narrower. "The trial answers a different question from the one being asked" is actionable; "the trial is flawed" is not.
-
Personal import allowances, compared — a second dataset Replied, post #61 · Access › International · 31 Jan 2026 · 6 likes An honest declaration on Personal import allowances: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than…
-
Trifluoroacetate content and its consequences Replied, post #45 · Analytics › Impurities & related substances · 29 Jan 2026 · 24 likes Practical experience of trifluoroacetate content, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make…
-
Guidelines revision: what changed and why — one year on Replied, post #63 · Meta › Announcements · 27 Jan 2026 · 7 likes The thing about Guidelines revision that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #68 · Pharmacology › Pharmacokinetics · 26 Jan 2026 · 1 like Careful with the language on Half-life. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Follow-up: Search filters: what is missing Replied, post #16 · Meta › Site feedback · 17 Jan 2026 · 2 likes Search filters is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #50 · Practice › Storage & stability · 13 Jan 2026 · 14 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. Someone should write this up properly,…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #37 · Compounds › Tirzepatide · 10 Jan 2026 · 10 likes If someone has run Reading SURMOUNT-1 without the press properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has…
-
A partial dose because the pen emptied mid-injection Replied, post #92 · Practice › Administration · 10 Jan 2026 · 0 likes Post #89 describes the usual case. This is about the unusual one. If you have to inject at a different time of day than usual, that is a much smaller perturbation than…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #84 · Compounds › Oral incretins · 9 Jan 2026 · 31 likes This follows post #81 rather than contradicting it. Taking the oral product with more water than instructed reduces absorption rather than helping it. That is…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #7 · Practice › Side effects · 26 Dec 2025 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
-
Storing lyophilised material long term: what governs the shelf life Replied, post #4 · Practice › Storage & stability · 23 Dec 2025 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. If you are going to test stored material, test it against a sample of the same…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #8 · Research Methods › N-of-1 designs · 5 Dec 2025 · 0 likes Practical experience of Pre-registering a personal experiment, offered as one case with the conditions stated, not as a general finding. Conditions first, because they…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #22 · Research Methods › N-of-1 designs · 25 Nov 2025 · 21 likes Thank you for the correction. I would rather find out here than later.
-
Sleep quality changes during weight loss — what changed since Replied, post #63 · Wellbeing › Sleep · 14 Nov 2025 · 12 likes Sleep-disordered breathing improving with weight reduction is one of the better-evidenced downstream effects, and the trial that measured it used an objective index…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #11 · Devices › Pens & autoinjectors · 30 Oct 2025 · 1 like Nothing here is medical advice, and pen technique is the single easiest thing to have demonstrated in person rather than learned from a description.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #39 · Analytics › Home & field testing · 26 Oct 2025 · 16 likes The practical version of home kit substitute is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #60 · Compounds › Tirzepatide · 21 Oct 2025 · 20 likes Adding the measurement that post #57 says would settle it. Gastrointestinal effects were comparable in character to the GLP-1 monoagonists across the programme.…
-
Sleep tracking data and its considerable limitations Replied, post #40 · Wellbeing › Sleep · 20 Oct 2025 · 0 likes Coming back to post #36, because the follow-up matters more than the original answer. A sleep diary with times rather than impressions is the only way to tell a real…
-
New subcategory: rationale and scope Replied, post #28 · Meta › Announcements · 15 Oct 2025 · 8 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
-
Where to report an adverse event officially, by region — a second dataset Replied, post #7 · Safety › Adverse events · 9 Oct 2025 · 28 likes Attribution is genuinely hard for a single case and the reporting schemes are designed to work with that. You are not expected to prove causation to file.
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #68 · Evidence › Preprints · 1 Oct 2025 · 11 likes Worth separating Citing a preprint as a question about the compound from Citing a preprint as a question about the documentation. They get answered by different people…
-
Reading SURMOUNT-1 without the press release Replied, post #21 · Compounds › Tirzepatide · 30 Sep 2025 · 8 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #101 · Compounds › Oral incretins · 14 Sep 2025 · 8 likes Saving this. It is the version I will quote when the question comes round again.
-
Payment method and the leverage it gives you, ranked Replied, post #9 · Sourcing › Payments · 14 Sep 2025 · 0 likes I would call the community position on payment method likely rather than established, and I would be comfortable defending that hedge.
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #41 · Compounds › Repair & healing peptides · 10 Sep 2025 · 22 likes For anyone finding this later: the short answer on BPC-157 is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
Hypertension improvement and when medication needs revisiting Replied, post #36 · Clinical › Comorbidities · 1 Sep 2025 · 0 likes Small methodological point on hypertension improvement: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
Sodium, potassium and magnesium when intake drops Replied, post #59 · Nutrition & Training › Hydration & electrolytes · 15 Jul 2025 · 8 likes Worth separating two things that post #55 runs together. Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte…
-
Sequence verification for an obscure compound: how it is done Replied, post #67 · Compounds › Other compounds · 19 Jun 2025 · 2 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #32 · Compounds › Semaglutide · 18 Jun 2025 · 3 likes Worth separating two things that post #30 runs together. STEP 1 and STEP 4 are two different questions. The first asks what happens when treatment is added; the second…
-
Coming back to: When "no data" is the complete and final answer Replied, post #10 · Compounds › Other compounds · 10 Jun 2025 · 3 likes Confirming post #9 from a second method, which matters more than confirming it from a second person. The honest summary for most of this subcategory: a plausible…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #22 · Sourcing › Regulatory · 10 Jun 2025 · 0 likes Taking compound being unapproved seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison,…
-
Regression to the mean in progress reports Replied, post #18 · Research Methods › Statistics · 8 Jun 2025 · 15 likes Regression to the mean: if you select people with extreme values (very high or very low), their next measurement is often less extreme just by chance. This can look…
-
Counter-ion content and its effect on measured mass Replied, post #55 · Analytics › Mass spectrometry · 3 Jun 2025 · 2 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory.
-
A newcomer's list of things that confused me, and the fixes Replied, post #11 · Start Here › Welcome · 26 May 2025 · 20 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #40 · Regional › UK & Ireland · 25 May 2025 · 0 likes Pharmacy supply: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Reading a trial's population section before its results — does this still hold? Replied, post #137 · Evidence › Trials · 23 May 2025 · 0 likes Entry criteria, run-in periods and the self-selection of people willing to enter a multi-year trial all narrow the population. That is how internal validity is bought…
-
Half-life, steady state, and accumulation worked through Replied, post #12 · Pharmacology › Pharmacokinetics · 22 May 2025 · 17 likes I read post #8 twice before replying, because I had assumed the opposite. I keep a log for half-life specifically because my memory of it turned out to be…
-
EU-wide position versus national implementation Replied, post #3 · Regional › European Union · 4 May 2025 · 0 likes Everything in the opening post holds. The case it does not cover is the one I have. Where the eu-wide position versus national implementation reasoning breaks down for…
-
Why "any advice?" is the least effective ending for a post — the long version Started this topic · Start Here › How to Ask · 3 May 2025 · 0 likes Asking directly, because I could not find a straight answer: Why "any advice?" is the least effective ending for a post — the long version Counting it rather than…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #132 · Evidence › Journal club · 23 Apr 2025 · 11 likes Post #130 put the caveat in the right place and I want to underline it. I read the earlier replies on STEP 1 twice before writing this, because I had assumed the…
-
Telehealth prescribing models in the US Replied, post #87 · Regional › North America · 20 Apr 2025 · 0 likes Post #83 put the caveat in the right place and I want to underline it. Both are useful and different. The account tells you what happens in practice; the criterion…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #17 · Evidence › Journal club · 16 Apr 2025 · 0 likes Adding the boring version of SURMOUNT-4 and continuation versus withdrawal, because the interesting version keeps getting posted and the boring one is usually right.…
-
[2026 update] Heterogeneity as information rather than as a nuisance Replied, post #2 · Evidence › Meta-analyses · 13 Apr 2025 · 21 likes Quality assessment of included trials should change the analysis rather than sit beside it. A sensitivity analysis excluding the weakest studies is the minimum. I have…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #63 · Compounds › Semaglutide · 3 Apr 2025 · 33 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
UK access routes, dated and sourced — a second dataset Replied, post #53 · Regional › UK & Ireland · 21 Mar 2025 · 0 likes I read post #49 twice before replying, because I had assumed the opposite. NHS access has been restricted by commissioning criteria, not by licensing. Specialist…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #118 · Sourcing › Vendor reports · 18 Mar 2025 · 1 like Date the submission as well as the result. Turnaround is part of what people want to know and it disappears if only one date is recorded. I would call that likely…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #76 · Evidence › Journal club · 12 Mar 2025 · 29 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. The variance…
-
Scheduled maintenance and what will be unavailable Replied, post #65 · Meta › Announcements · 7 Mar 2025 · 23 likes The documentation on scheduled maintenance is better than this thread and I say that as someone who has posted in the thread.
-
Criticising the method without criticising the authors Replied, post #44 · Evidence › Study critique · 3 Mar 2025 · 3 likes Defending a design that is being criticised unfairly is as useful as criticising one that deserves it, and it happens far less often. If anyone has run this properly I…
-
Consistent declarations and why they matter more than clever ones Replied, post #70 · Sourcing › Logistics · 22 Feb 2025 · 5 likes For anyone finding this later: the short answer on consistent declarations is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #127 · Evidence › Journal club · 14 Feb 2025 · 7 likes Confirming post #126 from a second method, which matters more than confirming it from a second person. The number people quote for SURPASS-2 is a central estimate…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #42 · Compounds › Secretagogues & GH axis · 8 Feb 2025 · 0 likes Adding a null result on pulsatile secretion. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
What changed in 2026, by region Replied, post #122 · Access › International · 5 Feb 2025 · 7 likes A first-hand dated account for a region with thin coverage is worth more here than any summary, and the regions with thin coverage are most of them. The mechanism is…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #29 · Practice › Reconstitution · 5 Feb 2025 · 12 likes On post #25 — agreed on the reasoning, with one qualification. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
-
Body image changing more slowly than the body Replied, post #67 · Wellbeing › Mental health · 18 Dec 2024 · 13 likes I read post #64 twice before replying, because I had assumed the opposite. The bit of body image that nobody enjoys is that the answer changes depending on what you are…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #15 · Clinical › Special populations · 20 Nov 2024 · 4 likes Post #12 answers the question as asked. The question underneath it is different. Athletes and people in substantial training loads are effectively unstudied, and the…
-
EMA product information as a primary source — does this still hold? Replied, post #67 · Regional › European Union · 16 Nov 2024 · 0 likes Post #63 put the caveat in the right place and I want to underline it. I would put moderate confidence on the mainstream reading of EMA product information and no more.…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #28 · Access › Insurance & coverage · 15 Nov 2024 · 6 likes Thank you for the correction. I would rather find out here than later.
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #27 · Compounds › Semaglutide · 15 Nov 2024 · 6 likes The 2.4 mg maintenance dose in the weight-management programme and the 1.0 mg diabetes dose are frequently discussed as though they were the same drug at different…
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #8 · Practice › Dosing & titration · 15 Nov 2024 · 0 likes Confirming post #7 from a second method, which matters more than confirming it from a second person. One more thing on Holding a dose that took me far too long to see:…
-
Why "any advice?" is the least effective ending for a post Replied, post #12 · Start Here › How to Ask · 6 Nov 2024 · 4 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #19 · Compounds › Tirzepatide · 2 Nov 2024 · 4 likes Post #18 is right about the mechanism and I think understates the practical bit. Heart rate rises modestly across this class, tirzepatide included. It is consistent,…
-
Progressive overload when the scale is falling — one year on Replied, post #140 · Nutrition & Training › Resistance training · 9 Oct 2024 · 2 likes Narrowing post #139, because the general version has more than one answer. Strength and hypertrophy respond to different things, and preserving one during a deficit is…
-
Why a preprint's supplementary material is often the best part Replied, post #40 · Evidence › Preprints · 27 Sep 2024 · 8 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Reporting a discrepancy without making an allegation Replied, post #47 · Sourcing › Vendor reports · 28 Aug 2024 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…